RECRUITING

Parent Management Training to Treat Irritability

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to see if 12 sessions of a Parent Management Training program can treat irritability in children aged 10-14 years old. The main question it aims to answer are: * Can a Parent Management Training for parents reduce anger outbursts and cranky moods in their children? * Can Parent Management Training be done in an outpatient clinic and do parents like it? Up to 18 families can join this study. This study will be used to set up a larger study in the Fall of 2025. Parent participants will complete 12 sessions of Parent Management Training for Irritability. Each session will be 45-55 minutes weekly. They will also participate in the assessments of their child before, during and after treatment. Child participants will do assessments before, during and after the Parent Management Training treatment.

Official Title

The Efficacy of Parent Management Training to Treat Irritability

Quick Facts

Study Start:2024-11-18
Study Completion:2025-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06020261

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:10 Years to 14 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * clinically significant irritability (Clinician Affective Reactivity Index 30 or greater)
  2. * parent or guardian willing to participate in treatment with the child
  1. * psychiatric instability (danger to self/others, risky substance abuse)
  2. * current active PTSD or a severe active stressor (e.g. child abuse)
  3. * history of severe psychopathology with an established alternate treatment (e.g. autism spectrum disorder, bipolar disorder, schizophrenia, intellectual disability)
  4. * general medical condition that may be driving irritability or prevent generalizable physiologic measures.
  5. * screen positive for an intellectual disability via WASI II estimated IQ\<70.

Contacts and Locations

Study Contact

Jami Moe-Hartman, MA
CONTACT
303-724-2259
jami.moehartman@cuanschutz.edu
Jessica Hawks, PhD
CONTACT
720-777-8214
jessica.hawks@childrenscolorado.org

Principal Investigator

Joel Stoddard, MD
PRINCIPAL_INVESTIGATOR
University of Colorado Denver, Anschutz Medical Campus
Joel Stoddard, MD
PRINCIPAL_INVESTIGATOR
University of Colorado Denver Anschutz

Study Locations (Sites)

Childrens Hospital Colorado
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Joel Stoddard, MD, PRINCIPAL_INVESTIGATOR, University of Colorado Denver, Anschutz Medical Campus
  • Joel Stoddard, MD, PRINCIPAL_INVESTIGATOR, University of Colorado Denver Anschutz

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-18
Study Completion Date2025-12-30

Study Record Updates

Study Start Date2024-11-18
Study Completion Date2025-12-30

Terms related to this study

Keywords Provided by Researchers

  • irritability
  • anger
  • parenting
  • temper outbursts
  • Parent Management Training

Additional Relevant MeSH Terms

  • Irritable Mood
  • Temper Tantrum
  • Anger